vs
Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $39.9M, roughly 1.9× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs 7.4%, a 13.2% gap on every dollar of revenue. Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 19.6%).
Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
CBAN vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $76.2M |
| Net Profit | $8.2M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 20.6% | 7.4% |
| Revenue YoY | — | 25.5% |
| Net Profit YoY | 24.1% | 30.7% |
| EPS (diluted) | — | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $39.9M | — | ||
| Q4 25 | $36.9M | $76.2M | ||
| Q3 25 | $32.8M | $71.9M | ||
| Q2 25 | $32.5M | $63.1M | ||
| Q1 25 | $30.0M | $59.1M | ||
| Q4 24 | $30.8M | $60.7M | ||
| Q3 24 | $28.6M | $58.0M | ||
| Q2 24 | $27.9M | $55.0M |
| Q1 26 | $8.2M | — | ||
| Q4 25 | — | $5.6M | ||
| Q3 25 | $5.8M | $3.5M | ||
| Q2 25 | $8.0M | $3.2M | ||
| Q1 25 | $6.6M | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $5.6M | $3.9M | ||
| Q2 24 | $5.5M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 25.9% | 11.0% | ||
| Q3 25 | 22.2% | 7.8% | ||
| Q2 25 | 30.9% | 8.1% | ||
| Q1 25 | 27.6% | 6.5% | ||
| Q4 24 | 28.8% | 10.6% | ||
| Q3 24 | 24.6% | 9.7% | ||
| Q2 24 | 24.8% | 6.6% |
| Q1 26 | 20.6% | — | ||
| Q4 25 | — | 7.4% | ||
| Q3 25 | 17.7% | 4.9% | ||
| Q2 25 | 24.6% | 5.0% | ||
| Q1 25 | 22.0% | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | 19.7% | 6.7% | ||
| Q2 24 | 19.6% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | $0.42 | $0.14 | ||
| Q3 25 | $0.33 | $0.09 | ||
| Q2 25 | $0.46 | $0.08 | ||
| Q1 25 | $0.38 | $0.06 | ||
| Q4 24 | $0.43 | $0.10 | ||
| Q3 24 | $0.32 | $0.10 | ||
| Q2 24 | $0.31 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $295.8M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $380.4M | $141.5M |
| Total Assets | $3.7B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $295.8M | — | ||
| Q4 25 | — | $13.5M | ||
| Q3 25 | — | $11.1M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $8.8M |
| Q1 26 | — | — | ||
| Q4 25 | $258.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $248.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $380.4M | — | ||
| Q4 25 | $375.9M | $141.5M | ||
| Q3 25 | $302.3M | $133.6M | ||
| Q2 25 | $293.9M | $139.7M | ||
| Q1 25 | $286.9M | $134.8M | ||
| Q4 24 | $278.7M | $131.4M | ||
| Q3 24 | $276.1M | $125.0M | ||
| Q2 24 | $264.7M | $119.4M |
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.7B | $199.2M | ||
| Q3 25 | $3.2B | $202.4M | ||
| Q2 25 | $3.1B | $184.6M | ||
| Q1 25 | $3.2B | $178.1M | ||
| Q4 24 | $3.1B | $177.1M | ||
| Q3 24 | $3.1B | $169.5M | ||
| Q2 24 | $3.0B | $163.9M |
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.89× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-5.5M | $18.4M | ||
| Q3 25 | $14.4M | $18.4M | ||
| Q2 25 | $15.8M | $12.3M | ||
| Q1 25 | $17.9M | $2.9M | ||
| Q4 24 | $23.4M | $15.0M | ||
| Q3 24 | $20.5M | $12.7M | ||
| Q2 24 | $1.1M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.9M | $9.7M | ||
| Q3 25 | $14.1M | $10.7M | ||
| Q2 25 | $15.8M | $4.1M | ||
| Q1 25 | $17.6M | $-12.6M | ||
| Q4 24 | $22.3M | $3.2M | ||
| Q3 24 | $20.2M | $1.7M | ||
| Q2 24 | $990.0K | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | -18.7% | 12.7% | ||
| Q3 25 | 42.9% | 14.9% | ||
| Q2 25 | 48.5% | 6.5% | ||
| Q1 25 | 58.7% | -21.4% | ||
| Q4 24 | 72.5% | 5.2% | ||
| Q3 24 | 70.6% | 3.0% | ||
| Q2 24 | 3.5% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 11.5% | ||
| Q3 25 | 1.1% | 10.6% | ||
| Q2 25 | 0.3% | 12.9% | ||
| Q1 25 | 1.2% | 26.2% | ||
| Q4 24 | 3.5% | 19.5% | ||
| Q3 24 | 1.0% | 19.0% | ||
| Q2 24 | 0.5% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.27× | ||
| Q3 25 | 2.48× | 5.23× | ||
| Q2 25 | 1.99× | 3.88× | ||
| Q1 25 | 2.71× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 3.64× | 3.29× | ||
| Q2 24 | 0.20× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
VMD
Segment breakdown not available.
